Company Name, Ticker, Customers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
TPST's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Tempest Therapeutics Inc News
Tempest Therapeutics Inc's Inventory Turnover Ratio
Tempest Therapeutics Inc's Asset Turnover
Tempest Therapeutics Inc Business Description
Tempest Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Tempest Therapeutics Inc Growth Rates
Tempest Therapeutics Inc Profitability
Tempest Therapeutics Inc Valuation
Tempest Therapeutics Inc Management Effectiveness
Tempest Therapeutics Inc Financial Strength
Tempest Therapeutics Inc Efficiency
Tempest Therapeutics Inc Dividend
Financials
Tempest Therapeutics Inc Business Segments
Tempest Therapeutics Inc Income Statement
Tempest Therapeutics Inc Balance Sheets
Tempest Therapeutics Inc Cash Flow Statement
Tempest Therapeutics Inc Geographic Information
Suppliers
Tempest Therapeutics Inc Suppliers Performance
TPST Suppliers Stock Performance
TPST Suppliers Growth Rates
TPST Suppliers Data
TPST Suppliers Efficiency
TPST Suppliers Management Effectiveness
TPST Suppliers Valuation
TPST Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Tempest Therapeutics Inc Market Share
Tempest Therapeutics Inc Competition Performance
Tempest Therapeutics Inc Competitors Results
TPST Competitors Stock Performance
TPST Competitors Growth Rates
TPST Workforce Efficiency at the Competitors
TPST Competitors Efficiency
TPST Competitors Management Effectiveness
TPST Competitors Valuation
Customers & Markets
Tempest Therapeutics Inc Customers Demand
TPST Customers Expenditure Growth Rates
TPST Customers Performance
TPST Customers Stock Performance
TPST Customers Growth Rates
TPST Workforce Efficiency at the Customers
TPST Customers Efficiency
TPST Customers Management Effectiveness
TPST Customers Valuation
TPST Customers by Companys' Segments
Charts & Quotes
Tempest Therapeutics Inc Comparison Charts
TPST OHLC Charts
TPST's Tehnical Upper Indicators
TPST's Tehnical Lower Indicators
TPST's Weekly Charts
TPST's Monthly Charts
Tempest Therapeutics Inc's Profile
Company Charts and Quotes
Tempest Therapeutics Inc News
Tempest Therapeutics Inc's Executive Officers
Tempest Therapeutics Inc's Income Statement
Tempest Therapeutics Inc's Balance Sheets
Tempest Therapeutics Inc's Cash Flow Statement
Tempest Therapeutics Inc's Profitability
Tempest Therapeutics Inc's Financials
TPST's Interest Coverage Ratio
Tempest Therapeutics Inc's Suppliers
Tempest Therapeutics Inc's Competitors
Tempest Therapeutics Inc's Markets & Customers
Tempest Therapeutics Inc's Market Share
TPST's Suppliers Performance
TPST's Competitors Management Effectiveness
TPST's Charts Chaikin Oscillator
Tempest Therapeutics Inc's Customers Growth Rates
Economic Indicators
Industry Data
Growth Rates Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Personal Income
News
Economy News
Stock News
Hotel & Leisure Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Tempest Therapeutics Inc
(
TPST
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Tempest Therapeutics Inc 's Yearly Free Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
TPST Annual Free Cash Flow Growth
2022
2021
2020
2019
2018
Y / Y Annual Free Cash Flow Change
-
-
-
-
-
Annual Free Cash Flow (in millions $)
$-31.63
$-26.09
$-30.46
$-41.62
$-23.68
TPST Company Profile
>>
Back to TPST Fundamentals at a Glance
>>
Back to TPST Growth Comparisons
Annual Free Cash Flow Growth Comment
Tempest Therapeutics Inc
realized free cash outflow.
Tempest Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2022 Annual Free Cash Flow within Healthcare Sector
Y/Y Free Cash Flow Growth %
2022 Annual Free Cash Flow
Align Technology inc
-64.12 %
$ 276.832 millions
Resmed Inc
-68.53 %
$ 195.111 millions
Teleflex Incorporated
-54.59 %
$ 263.616 millions
Arvinas Inc